| Ansøgningsnr. og dato | 19151147.6 (espacenet) (Federated) (European Patent Register), 20140731 | | Patent/reg.nr. og dato | DK/EP 3708583, 20220302 | | Tilgængelighedsdato | 20200916 | | Prioritetsnr. og dato | US 201361861198 P, 20130801, US 201361901732 P, 20131108, US 201461933632 P, 20140130 | | EP publ. nr. og dato |
EP 3708583 20200916 | | Løbedag | | | Ansøger/indehaver | Five Prime Therapeutics, Inc., 111 Oyster Point Boulevard
South San Francisco, CA 94080, US | | Ansøgers ref. nr. | 1625619 | | Opfinder | HAMBLETON, Julie, Five Prime Therapeutics, Inc.
111 Oyster Point Boulevard
South San Francisco, CA 94080, US,
HARDING, Thomas, Five Prime Therapeutics, Inc.
111 Oyster Point Boulevard
South San Francisco, CA 94080, US,
PIERCE, Kristen, Five Prime Therapeutics, Inc.
111 Oyster Point Boulevard
South San Francisco, CA 94080, US,
PATIL, Namrata, Five Prime Therapeutics, Inc.
111 Oyster Point Boulevard
South San Francisco, CA 94080, US,
BRENNAN, Thomas, Five Prime Therapeutics, Inc.
111 Oyster Point Boulevard
South San Francisco, CA 94080, US | | Fuldmægtig | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 31/337 (2006.01) , A61K 31/513 (2006.01) , A61K 33/24 (2019.01) , A61K 39/395 (2006.01) , A61P 1/00 (2006.01) , A61P 43/00 (2006.01) , C07K 16/28 (2006.01) , A61K 39/00 (2006.01) , A61P 35/00 (2006.01) | | Titel/benævnelse | IKKE-FUCOSYLEREDE ANTI-FGFR2IIIB-ANTISTOFFER | | Internationalt ansøgningsnr. | | | Internationalt publ. nr. | | | Relateret sag (certifikat) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
